Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

ARVINAS, INC. (ARVN) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

ARVINAS, INC. (ARVN), most recent 12 months reported: revenue $316.7M, net income $9.3M, free cash flow -$208.8M. Latest balance sheet on file: liquid cash $567.9M, total debt $300K, net cash $567.6M. From SEC filings. Others in Pharmaceutical Preparations: MANNKIND CORP · IRONWOOD PHARMACEUTICALS, INC. · SINOVAC BIOTECH LTD · XERIS BIOPHARMA HOLDINGS, INC. · EVOLUS, INC. · Aurinia Pharmaceuticals Inc. · LIGAND PHARMACEUTICALS INCORPORATED · Protagonist Therapeutics, Inc

Stock screener

Watchlist